The effect of the adenylate cyclase activator forskolin on bone resorption and cyclic AMP accumulation was studied in an organ-culture system by using calvarial bones from 6-7-day-old mice. Forskolin caused a rapid and fully reversible increase of cyclic AMP, which was maximal after 20-30 min. The phosphodiesterase inhibitor rolipram (30 ptmol/l), enhanced the cyclic AMP response to forskolin (50 /uimol/l) from a net cyclic AMP response of 1234 + 154 pmol/bone to 2854+ 193 pmol/bone (mean+ S.E.M., n = 4). The cyclic AMP level in bones treated with forskolin (30 limol/l) was significantly increased after 24 h of culture.
INTRODUCTION
Cyclic AMP has been implicated as a second messenger for the effects of parathyroid hormone (PTH), prostaglandin E2 (PGE2) and calcitonin (CT) on bone resorption (for a review, see Peck & Klahr, 1979) . However, this nucleotide only partially mimics the bone-resorptive effect of PTH and PGE2 inasmuch as a stimulation of bone resorption, in cultured mouse calvarial bones as well as in fetal-rat long bones, by dibutyryl cyclic AMP and phosphodiesterase (PDE) inhibitors can only be seen after a delay of 24-48 h (Lerner & Gustafson, 1981; McLeod & Raisz, 1981; Lerner et al., 1986a) . In short-term cultures ( < 24 h), cyclic AMP analogues and methylxanthines cause a transient inhibition of mineral mobilization (HerrmanErlee & van der Meer, 1974; Lerner, 1980a) . These results suggest that the inhibitory action of CT may be mediated intracellularly by cyclic AMP, but that the initial stimulatory effect by PTH and PGE2 is not.
Forskolin is a naturally occurring diterpene of the labdane family, obtained from the roots of the plant Coleusforskolii. It is a potent and reversible activator of most hormonally responsive adenylate cyclases and stimulates cyclic AMP accumulation in broken-cell preparations and intact tissues (Seamon & Daly 1981a) . The activation of adenylate cyclase by forskolin can be achieved without a functional guanine-nucleotidebinding subunit (Seamon & Daly, 1981b; Neer, 1978) , but recent data suggest that the subunit is required for Vol. 240 Abbreviations used: PTH, parathyroid hormone; PGE2 and PGI2 prostaglandins E2 and 12; CT, calcitonin; I4(OH)D3, la-hydroxycholecalciferol; LDH, lactate dehydrogenase; IBMX, 3-isobutylmethylxanthine; FCS, fetal-calf serum; PBS; phosphate-buffered saline, pH 7.5 (mmol/litre: CaCl2, 0.9; KCl, 3.7; KH2PO4, 1.7; MgC12, 1.1; NaCl, 137; Na2HPO4, 8.1); PDE, phosphodiesterase. a maximal response and for effects at low forskolin concentrations (Darfler et al., 1982; Seamon & Daly, 1985) .
We have recently found that forskolin increases cyclic AMP levels in cultured neonatal mouse calvaria and produces a transient inhibition of bone resorption followed by a delayed stimulation (Lerner et al., 1984) . In a preliminary report Lorenzo & Nishimoto (1982) found that forskolin, at high concentrations, inhibited bone resorption in fetal-rat long bones, both in short-term and long-term experiments. At lower concentrations forskolin stimulated bone resorption in long-term experiments. Martz & Thomas (1983) have found that forskolin can stimulate cyclic AMP accumulation in chick-embryo tibiae in vitro and that forskolin causes a biphasic stimulatory effect on Ca2+ efflux from these bones. Recently, Lowik et al. (1985) reported that forskolin is a weak transient stimulator of Ca2+ release from fetalmouse calvaria, although it induced a cyclic AMP response comparable with that induced by PTH. In order to investigate further the role of cyclic AMP in the hormonal response in bone tissue we have performed the present study with forskolin.
EXPERIMENTAL Materials
Forskolin (from Coleus forskolii, 7,f-acetoxy-8, 13-epoxy-1,6fl,9-trihydroxy-labd-14-ene-l 1-one) was purchased from Calbiochem-Behring Corp. Diagnostics, La Jolla, CA, U.S.A. CMRL 1066 and a-MEM (Minimal Essential Medium) media and fetal-calf serum were from Flow Laboratories, Irvine, Ayrshire, Scotland, U.K. 45CaCl2 (sp. radioactivity 20-40 Ci/g), [3H]adenosine 3',5'-cyclic monophosphate (26-38.5 Ci/mmol), Aquasol-2 and the radioimmunoassay kit for cyclic AMP were obtained from New England Nuclear Chemicals G.m.b.H., Dreieich, Germany. L-[5-3H]Proline (37 Ci/mmol) was from The Radiochemical Centre, Amersham, Bucks., U.K. Essentially fatty-acid-free bovine serum albumin (fraction V), phenolphthalein glucuronidate, p-nitrophenyl N-acetyl-D-glucosaminide and PGE2 were purchased from Sigma. Synthetic bovine parathyroid hormone (PTH 1-34) with a potency of 6800 i.u./mg was from Beckman, Geneva, Switzerland. Indomethacin was kindly supplied by Merck, Sharp and Dohme, Haarlem, The Netherlands. Synthetic salmon calcitonin with a potency of 5000/mg was kindly given by Sandoz AB, Basel, Switzerland. la exceed 0.1 % and this amount had no effect on basal 45Ca release nor on cyclic AMP levels in calvarial bones or isolated osteoblasts. PTH was dissolved, at a concentration of 1O itmol/l, in 1 mM-HCl containing 1 mg of albumin/ml and stored at -80 'C. The vehicle did not influence basal release of 45Ca. CT was dissolved as a stock solution (10 units/ml) in medium and stored at -80 'C. In most experiments forskolin was dissolved in ethanol just before incubation and diluted in culture medium to the appropriate concentration. However, in some experiments a stock solution of forskolin (10-30 mmol/l), stored at -20 'C, was used.
Methods
Measurements of bone resorption. The organ-culture technique used was that originally described by Reynolds (1976) . Calvarial bones (os frontale and parietale) were dissected from 6-7-day-old CsA mice, prelabelled with 1.5 ,uCi of 45Ca 4 days before the mice were killed (in the kinetic studies the mice were injected with 5 or 12.5 ,uCi of 45Ca). The calvaria were washed in ice-cold Tyrode's solution and divided along the sagittal suture into two halves. In most experiments calvaria from four to six different litters were pooled and randomized into different groups according to the experimental protocol. The half calvaria were cultured separately on stainlesssteel grids in plastic dishes (A/S Nunc, Copenhagen, Denmark) containing 5.5 ml of CMRL 1066 medium modified as described by Lerner & Gustafson (1979) . The cultures were gassed with C02/air (1:19) at 37 'C. In some experiments (see the legends to the figures) bones were precultured in indomethacin (1 ,umol/l) for 24 h (10 calvarial halves/10 ml of medium). After preculture the bones were washed three times in Tyrode's solution and further washed for 3 h in basic medium. Subsequently the bones were transferred to grids and cultured for the stated time periods with or without test substances. The preincubation technique improves the response to PTH and PGE2 by 75-100% as compared with the response in bones not precultured (U. H. Lerner, unpublished work) . After culture the bones were dissolved in 6 M-HCI and samples of the culture media and bones were analysed for radioactivity. The 45Ca release to culture medium was calculated as a percentage of initial radioactivity in bones (= bones +media after culture).
In the short-term kinetic studies (Fig. 4 below) the magnitude of mineral mobilization was determined by withdrawal of small amounts of culture medium (50-300 ,ul) at stated times and 45Ca release calculated as a percentage of initial radioactivity. These experiments were performed with paired half calvarial bones, i.e. one half of the individual calvarium was used as a control bone and the other half as an experimental bone.
The degradation of organic matrix was assessed either by monitoring the release of 3H from calvarial bones prelabelled with [3H]proline or by analysing the amount of hydroxyproline in bones after culture. Newborn CsA mice were injected with 10 ,Ci of [3H]proline 4 days before the mice were killed and calvarial bones dissected and cultured as described above. After culture the bones were hydrolysed for 20 h at 110 "C in sealed tubes containing 6 M-HCI. The hydrolysate was evaporated, redissolved in water and portions of bone hydrolysates and culture media were analysed for radioactivity in a liquid-scintillation counter. The c.p.m. values were corrected for quenching by using an external standard. Brand & Raisz (1972) found that the release of 3H is closely related to the release of [3H]hydroxyproline, and thus is a good indicator of collagen breakdown. In parallel with these experiments we cultured non-labelled bones in plastic dishes with 5 ml of medium and analysed the amounts of hydroxyproline in hydrolysates of bone after culture. Hydroxyproline was determined as described by Kivirikko et al. (1967) .
Measurement of lysosomal-and non-lysosomal-enzyme release. Half calvarial bones from non-labelled 5-7-day-old CsA mice were dissected and cultured as described above, except that the calvaria were cultured in dishes containing 2 ml of medium. The release of lysosomal enzymes from the bones to media was determined by assaying the activity of ,J-glucuronidase and /-N-acetylglucosaminidase in bones (enzymes liberated by treatment with 0.2% Triton X-100 for 24 h at 4 C) and media after culture. The assays of /8-glucuronidase and ,-N-acetylglucosaminidase were performed by measuring the hydrolysis of the appropriate glycoside of phenolphthalein and p-nitrophenyl respectively (Vaes & Jacques, 1965) . Lactate dehydrogenase (LDH) was assayed as a marker for cytosolic enzymes. The activity of LDH in bones and media was assayed by monitoring the oxidation rate of NADH at 340 nm and 25°C (Wroblewski & LaDue, 1955) . All the enzyme determinations were carried out under such conditions that the reactions were directly proportional both to amount of enzyme and incubation time.
The magnitude of bone resorption in the non-labelled calvaria was assessed by analysing the concentrations of stable calcium (Ca2+) and Pi in media before and after culture. Ca2+ was analysed by atomic-absorption spectrophotometry (Willis, 1970) and Pi by the method of Chen et al. (1956) .
Determination of cyclic AMP production in mouse calvaria. Half calvarial bones from non-labelled 5-7-day-old CsA mice were dissected carefully, pooled and randomized into different groups according to the experimental protocol. Bones were preincubated for 30 min in Erlenmeyer flasks containing 2 ml of prewarmed and pregassed CMRL 1066 medium (4 bones/flask), with or without the potent cyclic AMP PDE inhibitor rolipram (Lerner et al., 1986a) , at a concentration of 30 4mol/l. Subsequently 2 ml of medium, with or without test substances, was added to the flasks and incubation continued for the stated times. Preincubations and incubations were performed in a shaking water bath (40 oscillations/min) at 37 'C. At the end of the incubations bones were quickly transferred to tubes with 0.7 ml of 90%O (v/v) propan-l-ol and cyclic AMP extracted for 24 h at room temperature. The calvaria were removed and the extract evaporated (Ng et al., 1979) . Cyclic AMP was determined by the competitive binding method of Brown et al. (1972) .
Determination of cyclic AMP production in isolated osteoblasts. Bone cells were isolated from calvaria from 2-3-day-old mice with the modified sequential enzymedigestion technique described by Boonekamp et al. (1984) . On the basis ofhormone responsiveness (PTH and CT), populations 6 and 7 show characteristics of osteoblast-like cells. The osteoblast-like cells were suspended in a-MEM with 10% FCS and seeded in Linbro multiwell dishes at a density of 104 cells/cm2
(2 x 104 cells/well) in 0.5 ml of medium and incubated at 37 'C in C02/air (1: 19) . After attachment of cells overnight, fresh medium was added and replaced every 48 h. After 7 days, when the cell layers were confluent, the cells were carefully washed with prewarmed PBS and incubated for 30 min in oc-MEM without serum. Subsequently the cells were pretreated with the PDE inhibitor IBMX (0.2 mmol/l) and then challenged with test substances (in a-MEM without serum and with IBMX) at concentrations and times indicated in the legends to the Figures. At the end of the incubations the medium was drawn off and the reactions terminated by adding ice-cold PBS. Cyclic AMP in the cell layer was extracted with 90% (v/v) propan-1-ol for 24 h at 4 'C.
The extract was evaporated, redissolved in assay buffer and cyclic AMP analysed by radioimmunoassay using 1251-cyclic AMP as tracer. In one experiment cyclic AMP was also analysed in the culture medium drawn off the cells.
Calculations of EC50 and IC50 values. The concentrations for half-maximal stimulation (EC50) and halfmaximal inhibition (IC50) were obtained by Hill plots. log[R/(l-R)] was plotted versus log concentration of agonists. R is the response expressed as a value between 1 and 0, where 1 is maximal response. Linear regression was applied to the data and EC50 and IC50 values were calculated as the intercept with the x-axis.
Statistics. Statistical evaluation of the data was done using Student's t test for unpaired and paired observations.
RESULTS

Effect of forskolin on cyclic AMP levels in mouse calvarial bones
Forskolin, at concentrations of 30 and 50 #tmol/l, both in the absence and the presence of PDE inhibitor, caused an abundant and time-dependent stimulation of cyclic AMP formation in mouse calvarial bones (Fig. la) . The stimulatory effect of forskolin was clearly potentiated by the PDE inhibitor rolipram (Fig. la, inset ). After 60 s, forskolin (50,umol/1), in the presence of rolipram (30 #tmol/l), caused a 23-fold stimulation of cyclic AMP levels and after 24 min a maximal response (211-fold increase) was achieved. The stimulatory effect by forskolin on cyclic AMP was rapidly reversible when forksolin was omitted from the incubation medium (results not shown). Although the cyclic AMP levels in calvaria challenged with forskolin (30,cmol/1) declined after 1 h, significantly increased tissue levels of cyclic AMPcould still be seen after 24 h ofincubation (P < 0.01). The stimulation of cyclic AMP by forskolin, in the absence and the presence of the PDE inhibitor rolipram (30 gimol/1), was dose-dependent ( Fig. 2 ) and as appears from the inset, the threshold for action was close to 0.3 umol/l. The concentration required for half-maximal stimulation was 8.3 umol/l, calculated by the use of the Hill plot. Effects of forskolin on cyclic AMP levels in isolated osteoblast-like cells Forskolin, at a concentration of 30,umol/l, in the presence of the PDE inhibitor IBMX, caused a rapid cyclic AMP response in isolated osteoblasts. The cellular levels of cyclic AMP were maximal after 15 min and thereafter declined, reaching basal levels after 4 h (Fig.  lb) . The response to PTH (10 nmol/l) at the maximal time point (10 min) was of the same magnitude as the maximal response (15 min) to forskolin (30 ,mol/l). Effects of forskolin on the release of 45Ca and 3H from mouse calvarial bones cultured for 24 h Forskolin caused a dose-dependent inhibition of spontaneous 45Ca release from bones cultured for 24 h (Fig. 3a) and the calculated IC50 value was 1.6 ,tmol of forskolin/l. Maximal inhibition was seen at 10 lOmol/l. Fig. 3(b) demonstrates that the inhibitory effect by forskolin on 45Ca release in 24 h cultures could also be seen when bone resorption was stimulated by PTH (10 nmol/l). The calculated IC50 value in these experiments was 0.6,tmol/l, and at concentrations of 10 ,umol/l the effect of forskolin was maximal. PTH-stimulated release of 3H from [3H]proline-labelled bones was significantly and dose-dependently inhibited by forskolin Vol. 240 at and above 0.3 ,umol/l (Fig. 3c ). An inhibitory effect on PTH-stimulated 45Ca release by forskolin (10 and 1 gmol/l) could already be seen after 3 h of incubation (Fig. 4a ). An inhibition of forskolin (10 ,pmol/l) could also be seen in calvarial bones prestimulated by PTH (10 nmol/l) for 24 h (Fig. 4b) . The inhibition by forskolin (10 ,umol/l) in pre-stimulated bones was of the same magnitude as the inhibition by CT (100 munit/ml).
The inhibition of 45Ca mobilization by forskolin could be seen not only in PTH-stimulated bones but also in bones stimulated by la(OH)D3 and PGE2 (Fig. 5) . Incubation with PTH (10 nmol/l), la(OH)D3 (0.1 /tmol/l) and PGE2 (1 #tmol/l) stimulated 45Ca release from bones 1.6-, 1.4-and 1.6-fold respectively as compared with control bones. The addition of forskolin Fig. 6 demonstrates that the inhibition of 45Ca release by forskolin in short-term cultures was transient and that a stimulation of 45Ca release could be seen when the incubation time was extended to 120 h. The inhibition was maximal after 24 h, irrespective of the degree of inhibition. Forskolintreated bones started to release 45Ca at this time point.
The stimulatory effect of forskolin on 45Ca release in 120 h cultures was dose-dependent, with the threshold for action being 3 nmol/l (P < 0.05; Fig. 7 ). The calculated EC50 value was 16 nmol/l and maximal stimulation was obtained at ,mol/l (1.5-fold stimulation). The dose-response curve was biphasic, and above 3 ,smol of forskolin/l the stimulatory effect declined.
Forskolin had no effect on 45Ca release from bones devitalized by heating at 70°C for 5 min in culture medium (results not shown).
Forskolin significantly and dose-dependently increased the release of 3H from [3H]proline-labelled calvaria cultured for 120 h (Fig. 8) . The degree of stimulation was comparable with that obtained on mineral mobilization. In agreement with the curve for 45Ca release, the effect on 3H release declined at mol/l. At the end of a 120 h culture period, the amount of hydroxyproline in control bones was 39.9 + 2.0 ,ug/half calvaria (mean + S.E.M.; n = 7). In bones treated with PTH (10 nmol/l) or forskolin (1 ,umol/l) for 120 h the amount of hydroxyproline was significantly (P < 0.001) decreased to 14.1 + 2.3 and 23.1 + 2.1 ,ug/half calvaria (mean + S.E.M.; n = 7-8) respectively.
The stimulatory effect of forskolin (3 #tmol/l) on 45Ca release in 96 h cultures was significantly inhibited by addition of CT (0.1 unit/ml). By contrast, CT did not significantly inhibit 45Ca release in control bones (Fig. 9) inhibition '; Wener et al., 1972) . Although we can demonstrate 'escape from inhibition' by CT in PTH-stimulated bones in our system, we have, in three independent experiments, seen inhibition by CT in forskolinstimulated bones without any sign of 'escape from inhibition'.
Forskolin also caused a dose-dependent stimulation of 45Ca release in 120 h cultures of mouse calvaria treated simultaneously with indomethacin (I ,umol/l; results not shown). In the presence of indomethacin, forskolin (3 ,umol/l) caused a 2.19-fold (P < 0.001) stimulation of 45Ca mobilization.
Effect of forskolin on the release of Ca2 +, Pi, lysosomal and non-lysosomal enzymes from mouse calvarial bones cultured for 24 and 120 h PTH (10 nmol/) stimulated the release of Ca2+, Pi, fl-glucuronidase and ,-N-acetylglucosaminidase without affecting the release of LDH in 24 and 120 h cultures (Table 1) . In 24 h cultures, forskolin (10 ,umol/l) significantly inhibited the release of Ca2+, P,, ,-glucuronidase and ,J-N-acetylglucosaminidase from PTH-stimulated bones ( 
DISCUSSION
We have confirmed and extended our previous finding that the adenylate cyclase activator forskolin, both in the absence and the presence of a PDE inhibitor, stimulates cyclic AMP production in cultured mouse calvarial bones (Lerner et al., 1984) . The response is dose-dependent, with a threshold for action (cyclic AMP production) at 0.3,umol of forskolin/l, both in the absence and the presence of the PDE inhibitor rolipram. The EC50 value, 8.3 ,umol/l, is in good agreement with EC50 values reported for forskolin activation of cyclic AMP in most intact cell systems (Seamon & Daly, 1981a respectively (mean +S.E.M., n = 5) of the initial 45Ca. The stimulation of 45Ca release was statistically significant at and above a concentration of 3 nmol of forskolin/l (P < 0.05).
effect of forskolin degradation, since a full cyclic AMP response can be obtained in bones incubated in forskolin-containing medium that has previously been used for a 48 h incubation with mouse calvaria (results not shown).
According to the current view, PTH-stimulated cyclic AMP in bone is due to stimulation of osteoblasts. We therefore analysed the effect by forskolin on cyclic AMP in osteoblasts. Forskolin stimulated cyclic AMP production in osteoblasts isolated from neonatal mouse calvaria. The response was of the same order of magnitude as the response to PTH. As compared with the response in calvaria, forskolin-stimulated cyclic AMP in osteoblasts declined more rapidly. However, when total cyclic AMP (medium and cells) was assayed, the amount of cyclic AMP increased with time for at least 24 h (results not shown). This indicates that forskolin stimulates cyclic AMP production for long periods of time and that the cells acquire the capacity to extrude the nucleotide effectively.
Earlier studies with dibutyryl cyclic AMP (HerrmannErlee & van der Meer, 1974; Lerner & Gustafson, 1979; McLeod & Raisz, 1981) , PDE inhibitors and cyclic AMP analogues (Lerner, 1980a; Herrmann-Erlee & van der Meer, 1974) have demonstrated an inhibitory action of cyclic AMP on both spontaneous and stimulated bone resorption in short-term cultures (0-24 h). We show here that both spontaneous and stimulated bone resorption in Previous studies have indicated that there is an intimate relationship between the release of lysosomal enzymes and bone resorption (Eilon & Raisz, 1978; Lerner, 1980b,c; Vaes, 1980) . We show here that forskolin-induced inhibition of bone resorption is associated with decreased lysosomal-enzyme release. Since forskolin has no effect on the release of lactate dehydrogenase, as non-lysosomal enzyme, it seems that the inhibition of lysosomal-enzyme release is caused by an action on a specific degranulation process. This indicates that the effect of forskolin is cell-mediated. Earlier studies have demonstrated that dibutyryl cyclic AMP inhibits lysosomal-enzyme release in parallel with a decreased bone resorption (Lerner & Gustafson, 1979) . Moreover, when cyclic AMP, or its analogues, were combined with a PDE inhibitor, the inhibitory effect on lysosomal-enzyme release was potentiated (Lerner, 1 980a) . These results strongly indicate that an increase of cyclic AMP inhibits bone resorption and lysosomal degranulation. A similar inhibitory action of cyclic AMP on lysosomal degranulation has been reported in leukocytes (Zurier et al., 1974) .
The inhibitory action of forskolin on bone resorption in short-term cultures (present study) is in agreement with the findings in a preliminary report by Lorenzo & Nishimoto (1982) . Those authors reported that, in 2-day fetal-rat long-bone cultures, forskolin (10 /,mol/l) inhibited the release of 45Ca. Similarly, L6wik et al. (1985) recently reported that forskolin (5 and 10 ,umol/l) inhibited Ca2+ mobilization from fetal-mouse calvaria. When forskolin was added at a concentration of 0.1 ,umol/l, Ca2+ mobilization was stimulated in 6 h cultures (Lowik et al., 1985) . However, the effect was not sustained, and the magnitude was less than the effect by PTH at a dose giving the same cyclic AMP response. In a study by Martz & Thomas (1983) it was demonstrated that, in 2-8 h incubations, forskolin, at a concentration of 1 ,tmol/l, stimulated Ca2+ efflux from a chick-embryo system. However, in our system the forskolin-induced inhibition of bone resorption is transient (Lerner et al., 1984 ; the present study), and forskolin produces a dose-dependent stimulation of 45Ca and 3H release in long-term cultures (120 h; the present study). The kinetic studies reveal that, as long as cyclic AMP is elevated in Table 1 . Effect of forskolin on the release of Ca2+, Pi, lysosomal and non-lysosmal enzymes from mouse calvarial bones cultured for 24 and 120 h Non-labelled calvarial bones were dissected and precultured as described under 'Methods'. Subsequently bones were pooled and randomized into three groups according to experimental protocol. In Expt. 1, bones were cultured for 24 h in the absence or the presence of PTH (10 nmol/l) or in the presence of both PTH and forskolin (10 ,umol/l). In Expt. 2, bones were cultured for 120 h, in the absence and the presence of PTH (10 nmol/l) or forskolin (1 ,umol/l the bones, there is a decreased rate of bone resorption. When cyclic AMP has declined to basal levels (after 24 h) the bones start to resorb. In the study by Martz & Thomas (1983) , the cyclic AMP response was of much shorter duration than in our system. The divergent results on Ca2+ mobilization in short-term cultures (< 24 h) is not easily explained. However, the two studies showing an initial stimulatory effect by forskolin (Martz & Thomas, 1983; Lowik et al., 1985) use the release of stable Ca2+, which is the net effect of accretion and resorption processes, as a parameter of bone resorption, whereas we and Lorenzo & Nishimoto (1982) use 45Ca release to quantify the rate of resorption processes.
The dissociation between the dose-response curves for inhibition (IC50 1.6,umol/1) and stimulation (EC50 16 nmol/l) on mineral mobilization by forskolin indicates that, at low concentrations of forskolin, a delayed stimulation without a preceding inhibition can be obtained, in agreement with findings by Lorenzo & Nishimoto (1982) . The stimulatory effect by forskolin in long-term cultures is cell-mediated, as supported by the findings that forskolin not only stimulated mineral mobilization (45Ca, Ca2+, Pi), but also the release of lysosomal enzymes and the degradation of bone matrix (release of 3H from [3H]proline-labelled bones, amounts of hydroxyproline at the end of culture). Furthermore, no stimulation of 45Ca release by forskolin was seen in devitalized bones. Stimulation of 45Ca release was blocked by CT, indicating that the stimulatory effect of forskolin was at least partially osteoclasts-mediated. Indomethacin did not affect the stimulatory effect of forskolin on the release of 45Ca, suggesting that the stimulation is not prostaglandin-mediated. The delayed stimulation of bone resorption and release of lysosomal enzymes produced by the adenylate cyclase stimulator forskolin is in good agreement with the reported effect by dibutytryl cyclic AMP (Herrmann-Erlee & van der Meer, 1974; McLeod & Ralsz, 1981; Lerner & Gustafson, 1981) , PDE inhibitors (Herrmann-Erlee & van der Meer, 1974; Lerner & Gustafson, 1981; Lerner et al., 1986a) and cholera toxin (M. Ransjo & U. H. Lerner, unpublished work) . An interesting finding in the present study is that the biological effect of forskolin, in long-term cultures, can be seen at concentrations much lower (EC50 16 nmol/l) than those required to induce a measurable cyclic AMP response (EC50 8.3,mol/1). We have made similar observations using cholera toxin, PTH, PGE2, CT and PDE inhibitors as stimulants.
The cyclic AMP response to PTH is seen mainly in osteoblast-like cells, whereas the cyclic AMP response to calcitonin is only obtained in osteoclast-like cells (Luben et al., 1976) . We suggest that, when cyclic AMP in osteoclasts is elevated by CT, dibutyryl cyclic AMP, cholera toxin and forskolin, there is a decreased bone resorptive activity of the osteoclast. Further support for this view is provided by the work by Chambers & Ali (1983) , Chambers & Dunn (1983) and Chambers et al. (1985) , who demonstrated that CT, PGE2, PGI2, dibutyryl cyclic AMP but not PTH, inhibit the motility and boneresorptive capacity ofisolated osteoclasts. In line with the observations in isolated osteoclasts, we have recently found that PGE2 can acutely inhibit bone resorption in unstimulated mouse calvaria and that this effect can be potentiated by several PDE inhibitors (Lerner et al., 1986b ). Thus we propose that the initial bone-resorptive effect by PTH is not mediated by cyclic AMP. Instead, as indicated by the studies with forskolin, dibutyryl cyclic AMP, PDE inhibitors and cholera toxin, the nucleotide can be a mediator of the late bone-resorptive effect by PTH. Furthermore, we suggest that the delayed stimulation may be related to an increased number of osteoclasts via an elevation of cyclic AMP in osteoblasts or in osteoclast precursor cells. However, our speculation must await morphological data before it can be accepted.
